In a landmark judgment that has the potential to change the direction of India's pharmaceutical business, the Supreme Court said on Monday that the drug failed to qualify for a patent according to Indian law.
Bayer will not accept a ruling by the Intellectual Property Appellate Board in Chennai on Monday, upholding the compulsory licence granted on March 9 last year and it will appeal against the patent office order at the high court in Mumbai, a spokesperson told PTI.
Ahmedabad-based Zydus Cadila has made a foray into the US generic formulation segment by setting up a subsidiary Zydus Pharmaceuticals USA, Inc.
In a bid to tap overseas market, Glenmark Pharmaceuticals Ltd's wholly owned US subsidiary has entered into a product development and marketing licence agreement with US-based K V Pharmaceutical Company
The Pradhan Mantri Jan Aushadhi Yojana or PMJAY has not been a runaway success by any yardstick. Not all stores are running, and many are poorly stocked.
GVK Biosciences is the latest Indian firm to come under international scrutiny over quality issues.
An interview with Ranbaxy CEO and MD Arun Sawhney on the changes in the past four years and how the company plans to address the US concerns.
The Indian pharmaceutical players have the potential to corner about 25 per cent of the generic market amounting to $3.75 billion by 2007-08 through leveraging their low cost and technology advantage, according to Rabo India Finance report.
The merger has fortified Sun Pharma's position.
Financial pressure on the parent company triggered the move.
An insider said that over the past decade or so Cipla has become immune to the exits of leaders. There have been no directional change in the long-term strategies.
These two are now among India's most valuable business houses, ahead of older and more diversified groups, such as the Bajaj, OP Jindal, Anil Ambani, UB, Godrej and Hinduja.
The difference between watching a movie on a laptop in your apartment and watching it on a big white screen is almost spiritual, notes Sreehari Nair.
Observing that the economic recovery was not yet fully entrenched, the RBI Governor said recovery is likely to be gradual.
Lupin will be launching the generic version of Yasmin, a brand of Bayer Healthcare.
Drug major Ranbaxy Laboratories on Thursday said it plans to launch more generic products in the US market with possible marketing exclusivity, while keeping options open for overseas acquisitions to grow its business in various global markets.
'In states where all shops are allowed to function and pedestrians are allowed to move around, there is no reason to presume that vendors are not allowed to operate. But ambiguity surrounding the operation of street vendors de jure has led the police to harass them de facto,' say Bhuvana Anand, Jayana Bedi and Prashant Narang.
It was in 2005, India changed its patent law and started granting patents in medicines.
The Ranbaxy experience has made multinational corporations more cautious about Indian acquisitions in general
In 2012, drugs worth $35 billion went off-patent in the US, while the market size of drugs which will see patent expiry in 2013 will halve to $17 billion.
US election results may not reverse Indian markets' bearish trend, says Devangshu Datta
Indian government has set up a panel to fix prices of patented drugs in the country.
Demand will boom in the US and China, but exporters say it will be difficult for India to tap these markets.
For far too long, people in J&K have felt the government doesn't exist for them.' 'My first priority is to make them feel that not only does it exist, it is there to work for them.
Sun Pharmaceutical Industries Ltd Chairman Dilip Shanghvi said he expects Ranbaxy Laboratories Ltd to become profitable in the short term.
Ranbaxy Laboratories Ltd, which has profited handsomely by selling generic drugs in the United States, said on Tuesday it would increase its R&D spending by about 60 per cent over the next five years.
'In terms of a great first year, it was an amazing summer and hopefully, I can better that this time... Hopefully, against a side like India, testing yourself against one of the best bowling attacks in world cricket at the moment'
It is the first time that the JMI has been placed among the top 10 universities in the (HRD) Ministry's National Institutional Ranking Framework rankings.
'OPS did not back off.' 'He wanted transparency and he got it.'
A brand mascot personifies the brand very effectively. They have the capacity to create a better brand recall and strong positioning for a brand. Take this quiz to find out if these mascot have managed to leave a lasting impression.
This was not Sharad Pawar or Prithviraj Chavan speaking. It was Uddhav Thackeray, the undisputed chief of the Shiv Sena!
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances